Back to Search
TIMOTHY KUZEL, MD
MD
Medical Oncology Physician
NPI: 1851325088IndividualAccepts Medicare
Education
UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Class of 1984
Research & Publications (20)
Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497.
PMID 17943599·Leuk Lymphoma·2007
3-trial
Systemic chemotherapy for the treatment of mycosis fungoides and Sézary syndrome.
PMID 14686979·Dermatol Ther·2003
4-observational
Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancer.
PMID 12197218·Cancer Invest·2002
3-trial
DAB(389)IL-2 (denileukin diftitox, ONTAK): review of clinical trials to date.
PMID 11707861·Clin Lymphoma·2000
4-observational
Metastatic renal cell carcinoma with partial response to sunitinib complicated by ureteral obstruction from necrotic tumor.
PMID 18384863·Urology·2009
5-case
A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
PMID 19356897·J Pain Symptom Manage·2009
4-observational
NCCN clinical practice guidelines in oncology: testicular cancer.
PMID 19555582·J Natl Compr Canc Netw·2009
6-review
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
PMID 19636013·J Clin Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 675 N SAINT CLAIR ST, GALTER 21-100
CHICAGO, IL 60611 - Phone
- (312) 695-0990
Quick Facts
- NPI
- 1851325088
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile